MedTech Spectrum

Article Name Global/International

Starkey Unveils Omega AI Breakthrough in Hearing Technology

Omega AI represents Starkey's next major step toward transforming the hearing experience for patients worldwide

10th October, 2025

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

The clearances represent an important step forward in executing Fagron’s disciplined M&A strategy in Latin America

06th October, 2025

Olympus Initiates Global Removal of ViziShot 2 FLEX Needles Following Safety Reports

The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.

23rd September, 2025

BD Partners with Henry Ford Health to Pioneer Automated Pharmacy of the Future

The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care.

23rd September, 2025

Techsomed Secures FDA 510(k) Clearance for BioTraceIO360 Kidney Ablation Indication

The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care.

23rd September, 2025

Nicklaus Children’s Heart Institute Pioneers Bedside PDA Closures for Fragile Newborns Subheadline

The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants.

23rd September, 2025

Apollo Hospitals Launches Apollo Athenaa – Asia’s First Dedicated Cancer Centre for Women in New Delhi

The landmark centre, inaugurated by Delhi’s Chief Minister Smt. Rekha Gupta, sets a global benchmark in women-centric cancer care with a focus on dignity, privacy, and advanced treatment outcomes.

23rd September, 2025

NovaBone Unveils First Fully-Synthetic Bioactive Pre-Contoured Wedge at AOFAS 2025

Breakthrough bioactive glass device offers surgeons a safe, resorbable, and cost-effective alternative to metal implants, engineered to accelerate bone regeneration and streamline surgical workflow.

11th September, 2025

Vivos Files Critical Patent for Hydrogel Electron Beam Sterilisation

The validation was carried out under ISO 11137 by an international medical device accredited organisation

04th September, 2025

Siemens Healthineers and Evident Partner with Klinikum Ludwigshafen to Deliver Fully Digital Pathology Workflow

Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.

04th September, 2025

Abbott’s Navitor™ Wins CE Mark Expansion, Offering Minimally Invasive Valve Replacement to Low- and Intermediate-Risk Patients in Europe

Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management.

01st September, 2025

Hesperos’ Human-on-a-Chip® and Digital Twin Platforms Redefine Disease Modeling

CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.

13th August, 2025

Dräger Atlan A350 Series Earns Highest U.S. Cybersecurity Clearance for Medical Devices

Authority to Operate (ATO) certification from the U.S. Department of Defense affirms Dräger’s leadership in safeguarding patient data, delivering a fully ATO-certified anesthesia portfolio trusted by hospitals worldwide.

12th August, 2025

BD Becomes First MedTech Company to Earn Diamond-Level Resiliency Badge Across All HIRC Supply Chain Domains

BD’s Urology and Critical Care and Surgery units achieve top-tier recognition from the Healthcare Industry Resilience Collaborative, affirming its leadership in supply chain transparency, risk mitigation, and operational excellence

06th August, 2025

BD Invests $35M to Expand U.S. Production of PosiFlush™ Prefilled Syringes

The expansion at its Nebraska facility will boost syringe output by hundreds of millions annually, enhancing supply resilience and supporting safe, high-quality patient care across U.S. hospitals.

05th August, 2025

The FDA Is Phasing Out Animal Testing. Our Replacements Must Catch Up Fast.

In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead.

04th August, 2025

Demetra Launches Global Spine Division Following Strategic Acquisition of OrthoFundamentals

With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.

04th August, 2025

Galaxy Therapeutics Opens New 9,200 Sq. Ft. Facility to Support Global Scale-Up of Brain Aneurysm Solutions

Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.

31st July, 2025